Plasma Homocysteine and Insulin in Diabetic Nephropathy: Relationship to Body Mass Index

References

• Ueland P. M., Refsum H., Stabler S. P., Malinow M. R., Anderson A., Allen R. H. Total homocysteine in plasma or serum methods and clinical applications. Clin. Chem. 1993; 39: 1764–1779, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Boushey B. S., Beresford S. A., Omen G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular diseases: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–1057, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Verhoef P., Stampfer M. J., Buring J. E., Gaziano J. M., Allen R. H., Staber S. P., Reynolds R. D., Kok F. J., Hennekens C. H., Wilett W. C. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Am. J. Epidemiol. 1996; 143: 845–859, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chico A., Perez A., Cordoba A., Arcelus R., Carreras G., de Leiva A., Gonzalez‐Sastre F., Blanco‐Vaca F. Plasma homocysteine is related to albumin excretion rate in‐patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?. Diabetologia 1998; 41: 684–693, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fiorina P., Lanfredini M., Montanari A., Peca M. G., Veronelli A., Mello A., Astorri E., Craveri A. Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus. Am. J. Hypertens. 1998; 11: 1100–1107, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hoogeveen E. K., Kostense P. J., Jager A., Heine R. J., Jakobs C., Bouter L. M., Donker A. J., Stehouwer C. D. Serum homocysteine levels and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int. 1998; 54: 203–209, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Munshi M. N., Stone A., Fink L., Fonseca V. Hyperhomocysteinemia following a methionine load in patients with noninsulin dependent diabetes mellitus and macro vascular disease. Metabolism 1996; 45: 133–135, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Okada E., Oida K., Tada H., Aszuma K., Eguchi K., Tohda G., Kosaka S., Takahashi S., Miyamori I. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2000; 22: 484–490
   Web of Science ®Google Scholar
• Reaven G. M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1998; 37: 1595–1607
   Google Scholar
• Jacobs R. L., House J. D., Brosnan M. E., Brosnan J. T. Effects of streptozotocin‐induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 1998; 47: 1967–1970, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Das S., Reynolds T., Patnaik A., Rais N., Fink L. M., Fonxeca V. A. Plasma homocysteine concentrations in type 2 diabetic patients in India. J. Diabetes Its Complicat. 1999; 13: 200–203, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gallistl S., Erwa W., Sudi K., Borkenstein M., Mangge H. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care 2000; 23: 1348–1351, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva 1999
   Google Scholar
• Hofmann M. A., Kohl B., Zumbach M. S., Borcea V., Bierhaus A., Henkels M., Amiral J., Fiehn W., Zieglr R., Wahl P., Nawroth P. P. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care 1997; 20: 1880–1886
   PubMed Web of Science ®Google Scholar
• Hultberg B., Agardh E., Andersson A., Brattstrom L., Isakasson A., Isreaelsson B., Agardh C. D. Increased levels of plasma associated with nephropathy, but not sever retinopathy in type 1 diabetes mellitus. Scand. J. Clin. Lab. Invest. 1991; 51: 277–282, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Freidman A. N., Bostom A. G., Selhub J., Levey A. S., Rosenberg I. H. The kidney and homocysteine metabolism. J. Am. Soc. Nephrol. 2001; 12: 2181–2189
   PubMed Web of Science ®Google Scholar
• Hoogeveen E. K., Kostense P. J., Berks P. J., Makaay A. J., Jakobs C., Bouter L. M., Heine R. J., Stehouwer C. D.A. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non‐insulin depend diabetes mellitus: a population based study. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 133–138, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Giles W. H., Croft J. B., Greenlund K. J., Ford E. S., Kittner S. J. Total homocysteine concentration and the likelihood of nonfatal stroke. Results from the third National Health and Nutrition Examination Survey, 1988, 1994. Stroke 1998; 29: 2473–2477, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Araki A., Sako Y., Ito H. Plasma homocysteine concentrations in Japanese patients with non‐insulin dependent diabetes mellitus: effect of parental methylcobalamin treatment. Atherosclerosis 1993; 103: 149–157, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Giltay E. J., Hoogeveen E. K., Elbers J. H.M., Gooren L. J.G., Asscheman H., Stehouwer C. D.A. Insulin resistance is associated with elevated plasma total homocysteine levels in health, non obese subject. Atherosclerosis 1998; 139: 197–198, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Abbasi F., Facchini F., Humphreys M. H., Reaven G. M. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin‐mediated glucose disposal. Atherosclerosis 1999; 146: 175–178, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bar‐on H., Kidron M., Friedlander Y., Ben‐Yehuda A., Selhub J., Rosenberg I. H., Friedman G. Plasma total homocysteine levels in subjects with hyperinsulinemia. J. Intern. Med. 2000; 247: 287–294, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Soino M., Marniemi J., Laakso M., Lehto S., Rönnema T. Elevated plasma homocysteine levels is an independent predictor of coronary artery disease events in type 2 diabetes mellitus. Ann. Int. Med. 2004; 140(2)94–100
   PubMed Web of Science ®Google Scholar
• Bostom A. G., Lathrop L. Hyperhomocysteinemia in end‐stage renal disease: prevalence, etiology and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997; 52: 10–20, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Woo K. S., Chook P., Lolin Y. I., Cheung A. S., Chan L. T., Sunn Y. Y., et al. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997; 96: 2542–2544, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar